Canaccord Genuity Maintains Buy on Teladoc Health, Lowers Price Target to $25
Canaccord Genuity Maintains Buy on Teladoc Health, Lowers Price Target to $25
Canaccord Genuity 維持對 Teladoc Health 的買入,將目標股價下調至25美元
Canaccord Genuity analyst Richard Close maintains Teladoc Health (NYSE:TDOC) with a Buy and lowers the price target from $28 to $25.
Canaccord Genuity分析師理查德·克洛斯維持Teladoc Health(紐約證券交易所代碼:TDOC)的買入並將目標股價從28美元下調至25美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。